RTGOF yields 5128.21% · JNJ yields 2.13%● Live data
📍 RTGOF pulled ahead of the other in Year 1
Combined, RTGOF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of RTGOF + JNJ for your $10,000?
ArtGo Holdings Limited, an investment holding company, primarily engages in the mining, processing, trading, and sale of marble stones and commodity trading businesses in the People's Republic of China. It operates in two segments, Marble Products and Others. The company offers marble slabs, standard cut to size marble, antique series, water jet, border series, and marble-related crafts for bathroom and tailor-made household products; and calcium carbonate products. It also provides cargo handling services; and wholesales and retails decorating materials and chemical products. In addition, the company is involved in the provision of technical services for stone processing; warehousing, logistics, and sale of mineral products; and mining investment and mining planting projects. The company was formerly known as ArtGo Mining Holdings Limited and changed its name to ArtGo Holdings Limited in March 2015. ArtGo Holdings Limited was founded in 2009 and is headquartered in Shanghai, the People's Republic of China.
Full RTGOF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.